Search this website. You can use fund codes to locate specific funds

Authors

  • Amy Wilson
    With many companies opting for virtual shareholder meetings, how did investors ensure their concerns about climate change, diversity and human rights risks were addressed?
  • 28/03/2019
    EOS
    Bruce Duguid
    Investors can play a powerful role in tackling global challenges such as climate change or human rights issues by engaging with companies. But how can we ensure our efforts have the maximum impact?
  • Nicholas Spooner
    Just over one year on from the launch of Climate Action 100+ at the One Planet Summit in Paris, what have investors achieved?
  • Bruce Duguid
    BP is one of the world’s six oil and gas ‘supermajors’, operating in 72 countries. It is a vertically integrated business operating across exploration and production; refining; distribution and marketing; petrochemicals; power generation; and trading. It is also active in the area of renewable energy in particular biofuels production, wind farms and a new solar joint venture, as well as early stage investments in advanced mobility; bio-products; energy storage; and carbon capture and storage.
  • Bruce Duguid
    United Utilities is the second largest of 10 water and waste service companies in the UK, serving a population of approximately seven million people in the North West of England.
  • Bruce Duguid
    United Utilities is the second largest of 10 water and waste service companies in the UK, serving a population of approximately seven million people in the North West of England.
  • Bruce Duguid
    National Grid is one of the world’s largest publicly listed utilities. It focuses on the transmission and distribution of electricity and gas in the UK and the US.
  • Bruce Duguid
    GlaxoSmithKline (GSK) is a global healthcare business, with pharmaceutical, vaccines and consumer healthcare divisions. It employs over 100,000 employees and had a combined turnover of £27.9 billion (€31.8 billion/$37.7 billion) in 2016.
  • Bruce Duguid
    Shell is one of the largest oil and gas companies in the world, with upstream and downstream operations in over 70 countries. We have engaged with the company since 2003 on a broad range of issues, including corporate governance, the management of environmental risks and, in particular, the avoidance and response to oil spills in remote locations, such as the Arctic, as well as the impact of its oil sands operations.
  • Bruce Duguid
    Noting the company’s underperforming productivity in research and development and subsequently poor market rating at the time, our engagement with AstraZeneca was triggered by a share incentive scheme introduced in 2010. We voted against the scheme as its performance hurdles in dividend payments and dividend cover painted a bleak picture for the future of the business. Following this we met the company’s chair in 2011, which heightened our concerns on the company’s strategic direction and performance and left us questioning the quality of the board and the company’s leadership. AstraZeneca